We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

3 hedge funds and large institutions have $34.5M invested in Syneron Medical Ltd in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% less capital invested

Capital invested by funds: $235M → $34.5M (-$200M)

96% less funds holding

Funds holding: 79 → 3 (-76)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 74

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-76
Holders Change %
-96.2%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
74
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$25.7M
2
GLAM
Gardner Lewis Asset Management
Pennsylvania
-$17.4M
3
AA
AQR Arbitrage
Connecticut
-$16.2M
4
KPF
K2 Principal Fund
Ontario, Canada
-$12.1M
5
FTCM
First Trust Capital Management
Illinois
-$9.64M

ELOS Hedge Fund Activity: Q3 2017 in Review

3 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2017, worth a combined $34.5M — down 85% from $235M a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of ELOS and 0 opened new positions — a net loss of 74 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Camber Capital Management, exiting entirely with an estimated $25.7M sold.

  • 3 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2017, down from 79 in Q2 2017.
  • Funds reported $34.5M of Syneron Medical Ltd stock for Q3 2017, down 85% quarter-over-quarter.
  • 0 funds opened new Syneron Medical Ltd positions in Q3 2017 and 74 closed out, a net change of -74 holders.
  • The largest Syneron Medical Ltd seller in Q3 2017 was Camber Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q3 2017.